# VEGF Gene Transfer for Diabetic Neuropathy

> **NCT00056290** · PHASE1,PHASE2 · COMPLETED · sponsor: **Losordo, Douglas, M.D.** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **BIOLOGICAL:** VEGF
- **BIOLOGICAL:** VEGF

## Key facts

- **NCT ID:** NCT00056290
- **Lead sponsor:** Losordo, Douglas, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056290, "VEGF Gene Transfer for Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00056290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*